Clinical trial
A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers
NCT00392080 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00392080 |
|---|---|
| Title | A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers |
| Official title | A Multicenter, Randomized, Placebo And Active-Controlled Study Of The Effect Of CJ-023,423 On The Incidence Gastroduodenal Endoscopic Ulcers In Healthy Subjects |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | CJ-023, 423, placebo, naproxen |
| Enrollment | 340 |
| Start date | Nov 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Oct 25, 2006 |
| Last update posted | Mar 24, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: